ChemX Materials Secures $1.2m Loan Amid ASX Suspension

ChemX Materials remains suspended from ASX trading since December 2024, with no exploration activity reported in Q1 2026. The company secured an unsecured $1.2 million loan facility to support its recapitalisation and operational needs.

  • Shares suspended on ASX since December 2024
  • Unsecured $1.2 million loan facility with Ovay Pty Ltd
  • No exploration activities during the quarter
  • Related party payments of $40k disclosed
  • Available funding supports 6.3 quarters of operations
An image related to Chemx Materials Limited
Image © middle. Logo © respective owner.

Loan Facility Supports Recapitalisation Amid Suspension

ChemX Materials Limited (ASX:CMX) remains in trading suspension on the ASX, a status unchanged since 19 December 2024. The company has formalised an unsecured loan agreement with independent third party Ovay Pty Ltd, securing up to $1.2 million to fund operational obligations and advance its recapitalisation and restructuring efforts. The loan carries a 15% annual interest rate and is set to convert into fully paid ordinary shares upon a future capital raising linked to the company’s relisting, subject to shareholder approval.

During the quarter ended 31 March 2026, ChemX drew down an additional $131,000 under this facility, leaving $846,000 available. This funding arrangement is critical given the company’s ongoing suspension and limited cash inflows. The loan terms and Ovay’s financial capacity were subject to due diligence by ChemX’s board, which continues to engage with Ovay to ensure funding continuity as longer-term capital management options are evaluated. These developments build on the company’s previous announcement of the loan facility in March 2026, highlighting the importance of this funding in maintaining ChemX’s operational viability while suspended $1.2M loan with Ovay Pty Ltd.

Financial Reporting and Operational Status

Over the quarter, ChemX focused on bringing its financial reporting up to date, including completing quarterly reports and audit-reviewed half-year financial statements for the period ended 31 December 2025. Despite these compliance efforts, the company reported no exploration or production activities during the quarter, consistent with its suspended status and strategic pause on operations. Cash flow statements reveal operating outflows of $134,000 for the quarter and no cash on hand at quarter end, offset by the available loan facility that extends funding runway to approximately 6.3 quarters.

Prudent financial management remains a priority as ChemX navigates its path back to active trading. The company’s payments to related parties amounted to $40,000 in consulting fees paid to a director-related entity, disclosed in line with ASX listing rules. These payments reflect ongoing administrative costs amid limited operational activity and the company’s efforts to stabilise its financial position following its exit from voluntary administration in late 2025. ChemX’s journey through restructuring and recapitalisation continues, with the board actively managing compliance and funding to position the company for a potential relisting compliance amid ASX suspension.

No Exploration Activity and Future Uncertainties

The absence of exploration activity during the quarter underscores the company’s current focus on financial and structural matters rather than operational expansion. ChemX’s quarterly cash flow report confirms zero expenditure on exploration and evaluation, reflecting a strategic decision to conserve resources while recapitalisation efforts are underway. This cautious approach aligns with the company’s ongoing suspension and the need to satisfy ASX compliance requirements before trading can resume.

Looking ahead, ChemX’s ability to continue operations and meet its business objectives hinges on securing longer-term funding solutions and successfully navigating the relisting process. The company’s forward-looking statements caution that actual outcomes may differ materially due to risks and uncertainties inherent in its restructuring phase. Investors will be watching for updates on the progress of recapitalisation initiatives, changes in funding arrangements, and any signals on the timing of trading resumption.

Bottom Line?

ChemX’s secured loan facility provides a vital lifeline but the path to relisting remains uncertain amid ongoing suspension and no operational activity.

Questions in the middle?

  • What milestones will ChemX need to achieve to trigger a return to ASX trading?
  • How will the loan conversion to equity impact shareholder structure upon relisting?
  • What are the company’s plans for resuming exploration or operational activities post-recapitalisation?